Stoke Therapeutics grants options to buy 99,050 shares to 11 new employees
STOK•Stoke Therapeutics granted 11 new employees options to buy 99,050 common shares, effective November 16, 2026. The options have a 10-year term and vest over four years, subject to continued employment.
1. Option grant details
The options were granted under the 2023 Inducement Plan. Twenty-five percent vest on the first anniversary of the applicable vesting commencement date, with the remainder vesting monthly over the following 36 months, subject to continued employment.




